Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antithrombin and heparin.

R Carrell1, R Skinner, M Warden

  • 1Department of Haematology, University of Cambridge, MRC Centre, Hills Road, Cambridge, UK.

Molecular Medicine Today
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of physical activity, sedentary behaviour, diet, adiposity and body composition on health-related quality of life and cancer-related fatigue after diagnosis of colorectal cancer: a Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.

ESMO open·2025
Same author

Opportunities and challenges of tackling Scope 3 "Indirect" emissions from residential hot water.

Water research X·2023
Same author

Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children's cancer and Leukaemia Group (CCLG), and British Infection Association (BIA).

The Journal of infection·2022
Same author

The chance of transition: strategies for multidisciplinary collaboration.

Endocrine connections·2022
Same author

Characterizing CFTR modulated sweat chloride response across the cf population: Initial results from the CHEC-SC study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2022
Same author

The effect of exercise on vaccine-related pain, anxiety and fear during HPV vaccinations in adolescents.

Vaccine·2018
Same journal

Have tumor cells learnt from microorganisms how to fool the immune system? Escape from immune surveillance of tumors and microorganisms: emerging mechanisms and shared strategies.

Molecular medicine today·2001
Same journal

Molecular signalling in cardiovascular biology: from molecules to man. International symposium organized by the centre for cardiovascular biology and medicine, King's College, London.

Molecular medicine today·2001
Same journal

Is successful gene therapy for retinal disease in sight?

Molecular medicine today·2001
Same journal

New imaging techniques for early diagnosis of Alzheimer's disease.

Molecular medicine today·2001
Same journal

Knocking out NEMO.

Molecular medicine today·2001
Same journal

Clinical gene therapy back in the race.

Molecular medicine today·2001
See all related articles

Heparin activates antithrombin, a key thrombosis inhibitor, through a dynamic kinetic process. Understanding this molecular movie is crucial for preventing thrombotic diseases caused by mutations.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hematology

Background:

  • Antithrombin is the primary inhibitor of blood thrombosis.
  • Heparin-like side-chains in vasculature bind and activate antithrombin.
  • Mutations in the antithrombin heparin-binding site are linked to thrombotic disease.

Purpose of the Study:

  • To elucidate the kinetic mechanism of heparin-antithrombin interaction.
  • To move beyond static crystallographic snapshots towards a dynamic understanding of the process.

Main Methods:

  • Analysis of existing crystallographic models of antithrombin and heparin binding.
  • Focus on the kinetic aspects of binding, complex formation with thrombin, and release.

Main Results:

Related Experiment Videos

  • Detailed structural information exists for the heparin-binding site on antithrombin.
  • The interaction is a kinetic process involving sequential steps: binding, complex formation, and release.

Conclusions:

  • Current crystallographic models offer static snapshots, insufficient for understanding the mobile kinetic mechanism.
  • A dynamic, 'movie-like' understanding is needed to fully comprehend heparin-antithrombin interactions and their role in thrombosis.